CM Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$274K Buy
3,468
+258
+8% +$20.8K 0.05% 154
2026
Q1
$280K Hold
3,210
0.06% 119
2025
Q4
$311K Buy
+3,210
New +$312K 0.07% 110
2024
Q2
Sell
-3,699
Closed -$303K 137
2024
Q1
$303K Buy
+3,699
New +$316K 0.09% 135
2023
Q3
Sell
-2,758
Closed -$243K 134
2023
Q2
$243K Sell
2,758
-9,710
-78% -$836K 0.08% 133
2023
Q1
$1.12M Buy
+12,468
New +$1.02M 0.22% 130

Other funds holding MDT

CM Wealth Advisors's MDT Position: Q2 2026 in Review

CM Wealth Advisors increased its Medtronic (MDT) stake by 8% in Q2 2026, buying an estimated $20.8K and bringing the position to 3,468 shares worth $274K. The position accounts for 0.05% of the portfolio, ranked #154.

CM Wealth Advisors first reported a position in MDT in Q1 2023 and has held it in 6 quarters since. The position peaked at $1.12M in Q1 2023. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • CM Wealth Advisors held 3,468 shares of Medtronic worth $274K as of Q2 2026.
  • CM Wealth Advisors bought 258 Medtronic shares in Q2 2026, an estimated $20.8K.
  • Medtronic made up 0.05% of CM Wealth Advisors's portfolio in Q2 2026, its #154 holding.
  • CM Wealth Advisors first reported a position in Medtronic in Q1 2023 and has held it in 6 quarters since.
  • CM Wealth Advisors's Medtronic position peaked at $1.12M in Q1 2023.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on CM Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.